UB Paderborn / Katalog / Suche / in CDI

Action for Increasing Diversity, Market Access, and Capacity in Oncology Registration Trials—Is Africa the Answer? Report From a Satellite Session of the Accelerating Anti-Cancer Agent Development and Validation Workshop

JCO global oncology, 2022-06, Vol.8 (8), p.e2200117-e2200117

2022

Volltextzugriff (PDF)

A Review of the Evolving Landscape of Inclusive Research and Improved Clinical Trial Access

Clinical pharmacology and therapeutics, 2023-03, Vol.113 (3), p.518-527

2023

Volltextzugriff (PDF)

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

The New England journal of medicine, 2021-01, Vol.384 (1), p.20-30

2021

Volltextzugriff (PDF)

Characterization of 2-(2,6-dichloro-benzyl)-thiazolo[5,4- d]pyrimidin-7-yl]-(4-trifluoromethyl-phenyl)-amine (JNJ-39729209) as a novel TRPV1 antagonist

European journal of pharmacology, 2011-08, Vol.663 (1), p.40-50

2011

Volltextzugriff (PDF)

Discovery and synthesis of 6,7,8,9-tetrahydro-5H-pyrimido-[4,5-d]azepines as novel TRPV1 antagonists

Bioorganic & medicinal chemistry letters, 2010-12, Vol.20 (23), p.7137-7141

2010

Volltextzugriff (PDF)

3-[5-(3,4-Dichloro-phenyl)-1-(4-methoxy-phenyl)-1H-pyrazol-3-yl]-2-m-tolyl-propionate (JNJ-17156516), a novel, potent, and selective cholecystokinin 1 receptor antagonist: in vitro and in vivo pharmacological comparison with dexloxiglumide

The Journal of pharmacology and experimental therapeutics, 2007-11, Vol.323 (2), p.562

2007

Volltextzugriff (PDF)

Discovery of potent cholecystokinin-2 receptor antagonists: Elucidation of key pharmacophore elements by X-ray crystallographic and NMR conformational analysis

Bioorganic & medicinal chemistry, 2008-04, Vol.16 (7), p.3917-3925

2008

Volltextzugriff (PDF)

A novel, quantitative bio-assay for cholecystokinin type-1 receptor activity in the anaesthetised rat

Journal of pharmacological and toxicological methods, 2006-07, Vol.54 (1), p.36-41

2006

Volltextzugriff (PDF)

Niraparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and biallelic DNA-repair gene defects (DRD): Correlative measures of tumor response in phase II GALAHAD study

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.118-118

2020

Volltextzugriff (PDF)

Advancing Inclusive Research: Establishing Collaborative Strategies to Improve Diversity in Clinical Trials

Ethnicity & disease, 2022-01, Vol.32 (1), p.61-68

2022

Volltextzugriff (PDF)

Using Patient-Initiated Study Participation in the Development of Evidence for Personalized Cancer Therapy

Clinical cancer research, 2011-11, Vol.17 (21), p.6651-6657

2011

Volltextzugriff (PDF)

JNJ-26070109 [(R)4-bromo-N-[1-(2,4-difluoro-phenyl)-ethyl]-2-(quinoxaline-5-sulfonylamino)-benzamide]: a novel, potent, and selective cholecystokinin 2 receptor antagonist with good oral bioavailability

The Journal of pharmacology and experimental therapeutics, 2011-07, Vol.338 (1), p.328

2011

Volltextzugriff (PDF)

PHARMACOLOGICAL CHARACTERIZATION OF A PURINERGIC RECEPTOR (P2X7) ANTAGONIST IN‐VITRO AND IN‐VIVO

The FASEB journal, 2010-04, Vol.24 (S1), p.lb460-lb460

2010

Volltextzugriff (PDF)

Identification and Optimization of Anthranilic Sulfonamides as Novel, Selective Cholecystokinin-2 Receptor Antagonists

Journal of medicinal chemistry, 2006-10, Vol.49 (21), p.6371-6390

2006

Volltextzugriff (PDF)

Discovery and synthesis of 6,7,8,9-tetrahydro-5 H-pyrimido-[4,5- d]azepines as novel TRPV1 antagonists

Bioorganic & medicinal chemistry letters, 2010, Vol.20 (23), p.7137-7141

2010

Volltextzugriff (PDF)

1,2-Diamino-ethane-substituted-6,7,8,9-tetrahydro-5H-pyrimido[4,5-d]azepines as TRPV1 antagonists with improved properties

Bioorganic & medicinal chemistry letters, 2010-12, Vol.20 (23), p.7142-7146

2010

Volltextzugriff (PDF)

1,2-Diamino-ethane-substituted-6,7,8,9-tetrahydro-5 H-pyrimido[4,5- d]azepines as TRPV1 antagonists with improved properties

Bioorganic & medicinal chemistry letters, 2010, Vol.20 (23), p.7142-7146

2010

Volltextzugriff (PDF)

Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis

The New England journal of medicine, 2017-06, Vol.376 (22), p.2122-2133

2017

Volltextzugriff (PDF)

Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT)

American journal of kidney diseases, 2018-03, Vol.71 (3), p.352-361

2018

Volltextzugriff (PDF)

Biased Associative Representations in Parietal Cortex

Neuron (Cambridge, Mass.), 2013-01, Vol.77 (1), p.180-191

2013

Volltextzugriff (PDF)

Chronic exposure to arsenic and high fat diet induces sex-dependent pathogenic effects on the kidney

Chemico-biological interactions, 2019-09, Vol.310, p.108719-108719, Article 108719

2019

Volltextzugriff (PDF)

A living WHO guideline on drugs for covid-19

BMJ (Online), 2020-09, Vol.370, p.m3379

2020

Volltextzugriff (PDF)

Local community assembly mechanisms shape soil bacterial β diversity patterns along a latitudinal gradient

Nature communications, 2020-10, Vol.11 (1), p.5428-5428, Article 5428

2020

Volltextzugriff (PDF)

Mortality Relative Risks by Smoking, Race/Ethnicity, and Education

American journal of preventive medicine, 2023-04, Vol.64 (4), p.S53-S62

2023

Volltextzugriff (PDF)

Generalized associative representations in parietal cortex

Nature neuroscience, 2011-08, Vol.14 (8), p.1075-1079

2011

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Action for Increasing Diversity, Market Access, and Capacity in Oncology Registration Trials—Is Africa the Answer? Report From a Satellite Session of the Accelerating Anti-Cancer Agent Development and Validation Workshop

A Review of the Evolving Landscape of Inclusive Research and Improved Clinical Trial Access

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

Characterization of 2-(2,6-dichloro-benzyl)-thiazolo[5,4- d]pyrimidin-7-yl]-(4-trifluoromethyl-phenyl)-amine (JNJ-39729209) as a novel TRPV1 antagonist

Discovery and synthesis of 6,7,8,9-tetrahydro-5H-pyrimido-[4,5-d]azepines as novel TRPV1 antagonists

3-[5-(3,4-Dichloro-phenyl)-1-(4-methoxy-phenyl)-1H-pyrazol-3-yl]-2-m-tolyl-propionate (JNJ-17156516), a novel, potent, and selective cholecystokinin 1 receptor antagonist: in vitro and in vivo pharmacological comparison with dexloxiglumide

Discovery of potent cholecystokinin-2 receptor antagonists: Elucidation of key pharmacophore elements by X-ray crystallographic and NMR conformational analysis

A novel, quantitative bio-assay for cholecystokinin type-1 receptor activity in the anaesthetised rat

Niraparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and biallelic DNA-repair gene defects (DRD): Correlative measures of tumor response in phase II GALAHAD study

Advancing Inclusive Research: Establishing Collaborative Strategies to Improve Diversity in Clinical Trials

Using Patient-Initiated Study Participation in the Development of Evidence for Personalized Cancer Therapy

JNJ-26070109 [(R)4-bromo-N-[1-(2,4-difluoro-phenyl)-ethyl]-2-(quinoxaline-5-sulfonylamino)-benzamide]: a novel, potent, and selective cholecystokinin 2 receptor antagonist with good oral bioavailability

PHARMACOLOGICAL CHARACTERIZATION OF A PURINERGIC RECEPTOR (P2X7) ANTAGONIST IN‐VITRO AND IN‐VIVO

Identification and Optimization of Anthranilic Sulfonamides as Novel, Selective Cholecystokinin-2 Receptor Antagonists

Discovery and synthesis of 6,7,8,9-tetrahydro-5 H-pyrimido-[4,5- d]azepines as novel TRPV1 antagonists

1,2-Diamino-ethane-substituted-6,7,8,9-tetrahydro-5H-pyrimido[4,5-d]azepines as TRPV1 antagonists with improved properties

1,2-Diamino-ethane-substituted-6,7,8,9-tetrahydro-5 H-pyrimido[4,5- d]azepines as TRPV1 antagonists with improved properties

Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis

Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT)

Biased Associative Representations in Parietal Cortex

Chronic exposure to arsenic and high fat diet induces sex-dependent pathogenic effects on the kidney

A living WHO guideline on drugs for covid-19

Local community assembly mechanisms shape soil bacterial β diversity patterns along a latitudinal gradient

Mortality Relative Risks by Smoking, Race/Ethnicity, and Education

Generalized associative representations in parietal cortex

Suchergebnisse filtern